Skip to search formSkip to main contentSkip to account menu

Amphocil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The aim of this study was to compare the ultrastructural marks found in the renal tubules epithelium after two different formulas… 
Review
2003
Review
2003
The standard treatment of visceral leishmaniasis is pentavalent antimony (meglumine antimoniate or sodium stibogluconate), but… 
2002
2002
PURPOSE The objective of this study was to evaluate therapeutic and haemolytic effects of liposomal preparation derived from… 
Review
2001
Review
2001
Immunocompromised patients are well known to be predisposed to developing invasive fungal infections. These infections are… 
Review
2001
Review
2001
Spectrum of antimycotics used in treatment of systemic mycoses is comparatively poor. The oldest and till present received… 
1998
1998
Summary. Invasive aspergillosis is a feared complication in the management of patients with malignancies. We report a 13‐year‐old… 
Review
1996
Review
1996
Encapsulating amphotericin B (AmB) into liposomes or binding of AmB to other lipid carriers results in a significant reduction of… 
1996
1996
Three new and improved forms of amphotericin B (AmBisome, Amphocil, and Abelcet), all based on various lipid formulations, have…